Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Endocrinología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
Fase 3
ClinicalTrials.gov
Efficacy and Safety of Tirzepatide Once Weekly in Participants With Type 2 Diabetes Who Have Obesity or Are Overweight: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-2)
INTERVENTIONAL
Inicio: 29 de mar de 2021
ID: NCT04657003
Completado
Fase 3
ClinicalTrials.gov
A Randomised, Double-blind, Parallel-group, Multicentre, Phase III Study to Compare the Efficacy and Tolerability of Fulvestrant (FASLODEX) 500 mg With Anastrozole (ARIMIDEX) 1 mg as Hormonal Treatment for Postmenopausal Women With Hormone Receptor-Positive Locally Advanced or Metastatic Breast Cancer Who Have Not Previously Been Treated With Any Hormonal Therapy.
INTERVENTIONAL
Inicio: 17 de oct de 2012
ID: NCT01602380
Completado
Fase 3
ClinicalTrials.gov
A Comparison of LY2605541 Versus Human Insulin NPH as Basal Insulin Treatment in Insulin-Naïve Patients With Type 2 Diabetes Mellitus Not Adequately Controlled With 2 or More Oral Antihyperglycemic Medications: An Open-Label, Randomized Study
INTERVENTIONAL
Inicio: 1 de mar de 2013
ID: NCT01790438
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Placebo and Active Comparator-Controlled, Parallel-Group Study of the Efficacy and Safety of Rivoglitazone as Monotherapy Treatment of Type 2 Diabetes Mellitus
INTERVENTIONAL
Inicio: 23 de abr de 2007
ID: NCT00484198
Terminado
Fase 2
ClinicalTrials.gov
An Open Label Randomized Phase 2 Trial of Amcenestrant (SAR439859), Versus Endocrine Monotherapy as Per Physician's Choice in Patients With Estrogen Receptor-positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer With Prior Exposure to Hormonal Therapies
INTERVENTIONAL
Inicio: 22 de oct de 2019
ID: NCT04059484
Completado
Fase 2
ClinicalTrials.gov
A Double Blind, Placebo-Controlled, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of ISIS 404173 Administered Once Weekly to Obese Patients With Type 2 Diabetes Mellitus Being Treated With Metformin or Metformin Plus Sulfonylurea
INTERVENTIONAL
Inicio: 1 de ago de 2013
ID: NCT01918865
Terminado
Fase 3
ClinicalTrials.gov
A Double-Blind, Multi-Centre, Active-Controlled (15, 30, and 45 mg Pioglitazone) Long-Term Extension Study to Evaluate the Safety and Tolerability of Tesaglitazar (0.5 and 1 mg) in Patients With Type 2 Diabetes Mellitus (GALLEX 6)
INTERVENTIONAL
Inicio: 1 de mar de 2005
ID: NCT00226330
Reclutando
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY4064809 Combined With a CDK4/6 Inhibitor and Endocrine Therapy in Adults With HR+, HER2-Advanced Breast Cancer With a PIK3CA Mutation Who Received No Prior Treatment for Advanced Breast Cancer (PIKALO-2)
INTERVENTIONAL
Inicio: 22 de dic de 2025
ID: NCT07174336
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized Open-label Study of Pembrolizumab (MK-3475) Plus Olaparib Versus Abiraterone Acetate or Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) Who Are Unselected for Homologous Recombination Repair Defects and Have Failed Prior Treatment With One Next-generation Hormonal Agent (NHA) and Chemotherapy (KEYLYNK-010)
INTERVENTIONAL
Inicio: 2 de may de 2019
ID: NCT03834519
Terminado
Fase 3
ClinicalTrials.gov
A Phase 3 Double-Blind, Randomized, Placebo-Controlled Study to Determine the Efficacy, Safety, and Tolerability of AD-4833-536 in the Treatment of Subjects With Type 2 Diabetes
INTERVENTIONAL
Inicio: 1 de jun de 2006
ID: NCT00376181
Completado
Fase 3
ClinicalTrials.gov
Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo After an Intensive Lifestyle Program in Participants Without Type 2 Diabetes Who Have Obesity or Are Overweight With Weight-Related Comorbidities: A Randomized, Double Blind, Placebo-Controlled Trial (SURMOUNT-3)
INTERVENTIONAL
Inicio: 29 de mar de 2021
ID: NCT04657016
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of JNJ-28431754 on Cardiovascular Outcomes in Adult Subjects With Type 2 Diabetes Mellitus
INTERVENTIONAL
Inicio: 9 de dic de 2009
ID: NCT01032629
Completado
Fase 4
ClinicalTrials.gov
Two Approaches to Escalate Lispro Therapy in Patients With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on Basal Insulin Therapy and Oral Agents Alone (AUTONOMY)
INTERVENTIONAL
Inicio: 1 de dic de 2010
ID: NCT01215955
Completado
Fase 3
ClinicalTrials.gov
18-wk, International, Multi-centre, Randomized, Parallel-group, Double-Blind, Active-Controlled Phase IIIb Study to Evaluate the Efficacy and Safety of Saxagliptin in Combination With Metformin in Comparison With Sitagliptin in Combination With Metformin in Adult Patients With T2D Who Have Inadequate Glycaemic Control on Metformin Alone
INTERVENTIONAL
Inicio: 1 de abr de 2008
ID: NCT00666458
Completado
Fase 2
ClinicalTrials.gov
A Double-blind, Randomized 12-week Study to Evaluate the Safety and Efficacy of GSK189075 Tablets vs Pioglitazone in Treatment Naive Subjects With Type 2 Diabetes Mellitus
INTERVENTIONAL
Inicio: 23 de ene de 2007
ID: NCT00500331
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Open-label, Active-controlled, 2-arm Parallel-group, Multicenter 24-week Study Followed by an Extension Assessing the Efficacy and Safety of AVE0010 Versus Exenatide on Top of Metformin in Patients With Type 2 Diabetes Not Adequately Controlled With Metformin
INTERVENTIONAL
Inicio: 1 de jun de 2008
ID: NCT00707031
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, Blinded Efficacy and Safety Study of Pasireotide LAR vs Octreotide LAR in Patients With Metastatic Carcinoid Tumors Whose Disease-related Symptoms Are Inadequately Controlled by Somatostatin Analogues.
INTERVENTIONAL
Inicio: 1 de abr de 2008
ID: NCT00690430
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study Comparing the Efficacy and Safety of Tirzepatide Versus Placebo in Patients With Heart Failure With Preserved Ejection Fraction and Obesity (SUMMIT)
INTERVENTIONAL
Inicio: 20 de abr de 2021
ID: NCT04847557
Completado
Fase 3
ClinicalTrials.gov
Safety and Efficacy of Exenatide Once Weekly Versus Liraglutide in Subjects With Type 2 Diabetes and Inadequate Glycemic Control Treated With Lifestyle Modification and Oral Antidiabetic Medications
INTERVENTIONAL
Inicio: 1 de ene de 2010
ID: NCT01029886
Completado
Fase 1
ClinicalTrials.gov
A Two-Week, Randomized, Double-Blind, Repeat-Dose, Parallel-Group Study to Evaluate the Safety and Tolerability of Metformin > 2000mg Co-Administered With Either GSK189075 500mg BID or GSK 189075 750mg BID to Subjects With Type 2 Diabetes Mellitus
INTERVENTIONAL
Inicio: 11 de sept de 2007
ID: NCT00519480
Anterior
1
...
25
26
27
...
434
Siguiente
Filtros